Cognitive markers for efficacy of neurofeedback for attention-deficit hyperactivity disorder–personalized medicine using computational psychiatry in a randomized clinical trial

7Citations
Citations of this article
58Readers
Mendeley users who have this article in their library.

Your institution provides access to this article.

Abstract

Background: Exploring whether cognitive components (identified by baseline cognitive testing and computational modeling) moderate clinical outcome of neurofeedback (NF) for attention-deficit hyperactivity disorder (ADHD). Method: 142 children (aged 7–10) with ADHD were randomly assigned to either NF (n = 84) or control treatment (n = 58) in a double-blind clinical trial (NCT02251743). The NF group received live, self-controlled downtraining of electroencephalographic theta/beta ratio power. The control group received identical-appearing reinforcement from prerecorded electroencephalograms from other children. 133 (78 NF, 55 control) children had cognitive processing measured at baseline with the Integrated Visual and Auditory Continuous Performance Test (IVA2-CPT) and were included in this analysis. A diffusion decision model applied to the IVA2-CPT data quantified two latent cognitive components deficient in ADHD: drift rate and drift bias, indexing efficiency and context sensitivity of cognitive processes involving information integration. We explored whether these cognitive components moderated the improvement in parent- and teacher-rated inattention symptoms from baseline to treatment end (primary clinical outcome). Results: Baseline cognitive components reflecting information integration (drift rate, drift bias) moderated the improvement in inattention due to NF vs. control treatment (p = 0.006). Specifically, those with either the most or least severe deficits in these components showed more improvement in parent- and teacher-rated inattention when assigned to NF (Cohen’s d = 0.59) than when assigned to control (Cohen’s d = −0.21). Conclusions: Pre-treatment cognitive testing with computational modeling identified children who benefitted more from neurofeedback than control treatment for ADHD.

Cite

CITATION STYLE

APA

Ging-Jehli, N. R., Kraemer, H. C., Eugene Arnold, L., Roley-Roberts, M. E., & deBeus, R. (2023). Cognitive markers for efficacy of neurofeedback for attention-deficit hyperactivity disorder–personalized medicine using computational psychiatry in a randomized clinical trial. Journal of Clinical and Experimental Neuropsychology, 45(2), 118–131. https://doi.org/10.1080/13803395.2023.2206637

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free